These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 10477366)

  • 1. Colon cancer: p53 expression and DNA ploidy. Their relation to proximal or distal tumor site.
    García-Hirschfeld García J; Blanes Berenguel A; Vicioso Recio L; Márquez Moreno A; Rubio Garrido J; Matilla Vicente A
    Rev Esp Enferm Dig; 1999 Jul; 91(7):481-8. PubMed ID: 10477366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunoreactivity evaluation of mutant p53 gene product with DNA ploidy pattern in colorectal carcinoma.
    Nasif WA; El-Emshaty HM; Tabll A; Elmasry SA; Attallah AM; Gad Elhak NA
    Hepatogastroenterology; 2004; 51(58):1001-6. PubMed ID: 15239234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Have p53 gene mutations and protein expression a different biological significance in colorectal cancer?
    Bazan V; Migliavacca M; Tubiolo C; Macaluso M; Zanna I; Corsale S; Amato A; Calò V; Dardanoni G; Morello V; La Farina M; Albanese I; Tomasino RM; Gebbia N; Russo A
    J Cell Physiol; 2002 May; 191(2):237-46. PubMed ID: 12064467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA flow cytometry, p53 levels and proliferative cell nuclear antigen in human colon dysplastic, precancerous and cancerous tissues.
    Barletta A; Marzullo F; Pellecchia A; Montemurro S; Labriola A; Lomonaco R; Grammatica L; Paradiso A
    Anticancer Res; 1998; 18(3A):1677-82. PubMed ID: 9673389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of p53 protein overexpression and DNA ploidy analysis in colon cancer.
    Attallah AM; Elhak NG; Nasif WA; Tabll A; Ezzat F
    Hepatogastroenterology; 1997; 44(18):1595-601. PubMed ID: 9427029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of proliferation, apoptosis, defective DNA mismatch repair, and p53 overexpression in patients with resected Dukes' B2 or C colon cancer: a North Central Cancer Treatment Group Study.
    Garrity MM; Burgart LJ; Mahoney MR; Windschitl HE; Salim M; Wiesenfeld M; Krook JE; Michalak JC; Goldberg RM; O'Connell MJ; Furth AF; Sargent DJ; Murphy LM; Hill E; Riehle DL; Meyers CH; Witzig TE;
    J Clin Oncol; 2004 May; 22(9):1572-82. PubMed ID: 15117979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of tumor localization on the prognostic value of P53 protein in colorectal adenocarcinomas.
    Diez M; Medrano M; Mugüerza JM; Ramos P; Hernandez P; Villeta R; Martín A; Noguerales F; Ruiz A; Granell J
    Anticancer Res; 2000; 20(5C):3907-12. PubMed ID: 11268475
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA ploidy pattern and tumor suppressor gene p53 expression in gallbladder carcinoma.
    Roa I; Villaseca M; Araya JC; Roa J; de Aretxabala X; Fuentealba P; Melo A
    Cancer Epidemiol Biomarkers Prev; 1997 Jul; 6(7):547-50. PubMed ID: 9232344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [DNA ploidy pattern and p53 overexpression in gastric cancer].
    Tomisaki S; Tatsuo O; Hisao O; Sakaguchi Y; Kusumoto T; Ohno S; Ichiyoshi Y; Maehara Y; Sugimachi K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():115-7. PubMed ID: 7611772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [An immunohistochemical study of the relationship between p53 expression and the DNA ploidy pattern using image cytometry in colorectal carcinoma].
    Miki T; Funahashi K; Tsujita K; Takatsuki M; Koike J; Kubota S; Goto T; Nagasawa Y; Kobayashi K; Yanagita K
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():130-3. PubMed ID: 7611775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of p53 expression, cellular proliferation, and DNA content as prognostic indicators in renal cell carcinoma.
    Papadopoulos I; Rudolph P; Weichert-Jacobsen K
    Eur Urol; 1997; 32(1):110-7. PubMed ID: 9266242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection of p53 protein overexpression versus gene sequencing in urinary bladder carcinomas.
    Bernardini S; Adessi GL; Billerey C; Chezy E; Carbillet JP; Bittard H
    J Urol; 1999 Oct; 162(4):1496-501. PubMed ID: 10492244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study.
    Bazan V; Migliavacca M; Zanna I; Tubiolo C; Corsale S; Calò V; Amato A; Cammareri P; Latteri F; Grassi N; Fulfaro F; Porcasi R; Morello V; Nuara RB; Dardanoni G; Salerno S; Valerio MR; Dusonchet L; Gerbino A; Gebbia N; Tomasino RM; Russo A
    J Cancer Res Clin Oncol; 2002 Dec; 128(12):650-8. PubMed ID: 12474051
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistological p53 staining is of limited value in the staging and prognostic prediction of colorectal cancer.
    Kressner U; Lindmark G; Gerdin B; Påhlman L; Glimelius B
    Anticancer Res; 1996; 16(2):951-7. PubMed ID: 8687158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Male and female breast cancer--differences in DNA ploidy, p21 and p53 expression reinforce the possibility of distinct pathways of oncogenesis.
    André S; Pinto AE; Laranjeira C; Quaresma M; Soares J
    Pathobiology; 2007; 74(6):323-7. PubMed ID: 18087196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M; Saito H; Kondo A; Tsujitani S; Maeta M; Kaibara N
    Hepatogastroenterology; 1999; 46(28):2648-53. PubMed ID: 10522058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Analysis of p53 expression and DNA ploidy pattern in esophageal cancer].
    Naitoh H; Kawaguchi A; Shibata J; Umeda T; Kodama M; Hattori T
    Gan To Kagaku Ryoho; 1995 Jun; 22 Suppl 2():110-4. PubMed ID: 7611771
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The expression of mutation p53 gene from circulating cancer cells of peripheral blood and the clinical significance in detecting the patients with colorectal cancer].
    Ma GJ; Zhou JN; Shen ZL; Chen SQ; Zhu YQ; Wu XL; Xue KX
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):186-8. PubMed ID: 16604493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of p53 expression and DNA ploidy pattern in colorectal cancer].
    Nakamura T; Hishiki S; Baba S
    Gan To Kagaku Ryoho; 1993 Apr; 20(6):780-3. PubMed ID: 8489286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.